Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition. (2018)
Attributed to:
MICA: Immunotherapy for oral cancer prevention and treatment
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201807-1250le
PubMed Identifier: 30141960
Publication URI: http://europepmc.org/abstract/MED/30141960
Type: Journal Article/Review
Volume: 198
Parent Publication: American journal of respiratory and critical care medicine
Issue: 11
ISSN: 1073-449X